Biofilm Formation in Clinical Settings and Its Implications

Biofilm formation in clinical settings poses significant challenges for infection management, as biofilms are associated with chronic infections and resistance to conventional antimicrobial therapies. This review discusses the multi-stage process of biofilm formation, including initial attachment, maturation, and dispersal mechanisms. It also highlights the pathogenicity of biofilms in various clinical scenarios, such as indwelling medical devices, chronic wound infections, and cystic fibrosis. The inherent resistance mechanisms of biofilm-associated microorganisms contribute to treatment difficulties, often leading to persistent infections. The review explores emerging therapeutic strategies, including disruption of biofilm formation, novel anti-biofilm agents, and combination therapies, aiming to improve treatment outcomes. Understanding biofilm dynamics is essential for developing effective diagnostic and management approaches to reduce the burden of biofilm-associated infections.